glp-1 agonists thyroid cancer Receptor in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways GLP-1RA and thyroid cancer: New

Ma et al

Analyses of medical records for people with diabetes or obesity have found a lower risk of AUD among those treated with a GLP-1

Furthermore, urinary infections are not significantly higher for PTDM patients and can be managed with standard treatments. Combination therapies involving GLP-1 agonists and SGLT-2 inhibitors have shown promise in managing co-morbidities associated with liver transplant recipients

[DOI] [PMC free article] [PubMed] [Google Scholar] 7.van Bloemendaal L, et al

Ushakumari DS, Sladen RN

Sanofi is also dealing with the decline in insulin sales due to newer insulin products and biosimilars, which puts pressure on its pipeline